267 related articles for article (PubMed ID: 9445322)
1. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
2. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
[TBL] [Abstract][Full Text] [Related]
4. Hyperacute stroke therapy with tissue plasminogen activator.
Alberts MJ
Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
[TBL] [Abstract][Full Text] [Related]
5. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
[TBL] [Abstract][Full Text] [Related]
7. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia].
Dávalos A; Alvarez-Sabín J; Martí-Vilalta JL; Castillo J;
Med Clin (Barc); 2003 Jan; 120(1):1-5. PubMed ID: 12525296
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator for acute ischemic stroke.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
[TBL] [Abstract][Full Text] [Related]
10. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
12. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.
Grond M; Stenzel C; Schmülling S; Rudolf J; Neveling M; Lechleuthner A; Schneweis S; Heiss WD
Stroke; 1998 Aug; 29(8):1544-9. PubMed ID: 9707190
[TBL] [Abstract][Full Text] [Related]
13. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
14. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
15. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
17. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.
Brott TG; Haley EC; Levy DE; Barsan W; Broderick J; Sheppard GL; Spilker J; Kongable GL; Massey S; Reed R
Stroke; 1992 May; 23(5):632-40. PubMed ID: 1579958
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.
Tanne D; Bates VE; Verro P; Kasner SE; Binder JR; Patel SC; Mansbach HH; Daley S; Schultz LR; Karanjia PN; Scott P; Dayno JM; Vereczkey-Porter K; Benesch C; Book D; Coplin WM; Dulli D; Levine SR
Neurology; 1999 Jul; 53(2):424-7. PubMed ID: 10430444
[TBL] [Abstract][Full Text] [Related]
19. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
IMS Study Investigators
Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
[TBL] [Abstract][Full Text] [Related]
20. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
